Publications by authors named "Amy Marren"

Claim this Profile
C
Correction to: Characterization of Creatine Kinase Levels in Tofacitinib‑Treated Patients with Ulcerative Colitis: Results from Clinical Trials.
Remo Panaccione, John D Isaacs, Lea Ann Chen, Wenjin Wang, Amy Marren

Dig Dis Sci· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials.
Remo Panaccione, John D Isaacs, Lea Ann Chen, Wenjin Wang, Amy Marren

Dig Dis Sci· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Drug Monitoring for Current and Investigational Inflammatory Bowel Disease Treatments.
Scott D Lee, Raina Shivashankar, Daniel Quirk, Haiying Zhang, Jean-Baptiste Telliez, Amy Marren

J Clin Gastroenterol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter: corticosteroid use alongside tofacitinib in OCTAVE Open. Authors' reply.
Bruce E Sands, Alessandro Armuzzi, John K Marshall, James O Lindsay, William J Sandborn, Amy Marren

Aliment Pharmacol Ther· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of tofacitinib dose de-escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open.
Bruce E Sands, Alessandro Armuzzi, John K Marshall, James O Lindsay, William J Sandborn, Amy Marren

Aliment Pharmacol Ther· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient and physician preferences for ulcerative colitis treatments in the United States.
Marco Boeri, Kelley Myers, Claire Ervin, Amy Marren, Marco DiBonaventura

Clin Exp Gastroenterol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative Colitis.
Uma Mahadevan, Marla C Dubinsky, Chinyu Su, Nervin Lawendy, Thomas V Jones, Amy Marren

Inflamm Bowel Dis· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of biologics in inflammatory bowel disease.
Séverine Vermeire, Ann Gils, Paola Accossato, Sadiq Lula, Amy Marren

Therap Adv Gastroenterol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials.
Julian Panés, William J Sandborn, Stefan Schreiber, Bruce E Sands, Séverine Vermeire, Amy Marren

Gut· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ulcerative Colitis Treatment Patterns and Cost of Care.
Kyle D Null, Yihua Xu, Margaret K Pasquale, Chinyu Su, Amy Marren

Value Health· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tofacitinib is not a biologic.
Amy S Marren

Ann Gastroenterol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis.
Megan E B Clowse, Steven R Feldman, John D Isaacs, Alexandra B Kimball, Vibeke Strand, Amy Marren

Drug Saf· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis